JAMA · 1982 · 24 citations · 8 references
MedicineEndocrinologySurgeryBone MetabolismChemotherapyMineral MetabolismBone Metabolism DisordersCalcium DisordersMetabolic Bone DiseaseParathyroid DisordersParathyroid SurgerySurgical Management Of HyperparathyroidismHyperparathyroid Bone DiseaseLytic Bone LesionsMultiple Myeloma ChemotherapyMultiple Myeloma Of BoneMyeloma Bone DiseaseParathyroid PathologyPrimary Hyperparathyroidism-associated TumorsSerum Calcium Measurement
A patient with multiple myeloma and hypercalcemia responded to cytotoxic chemotherapy. However, hypercalcemia persisted. Because of the absence of lytic bone lesions, the presence of a low serum phosphate level, and a family history of possible primary hyperparathyroidism, the patient was evaluated for this disorder. Serum parathyroid hormone and urinary cyclic adenosine monophosphate levels were elevated. Exploration of the neck disclosed two enlarged parathyroid glands (1,850 mg and 210 mg), which were excised. After surgery, the patient's serum calcium levels remained normal for one year. Progressive myeloma bone disease developed that eventually resulted in recurrent hypercalcemia and death. Autopsy revealed only evidence of myeloma.
8
Biochemical Evaluation of Patients with Cancer-Associated Hypercalcemia
Andrew F. Stewart, Ronald L. Horst, Leonard J. Deftos et al. · New England Journal of Medicine · 1980 · 720 citations
Medicine, Endocrinology, Oncology +17
The clinical spectrum of light chain myeloma
Marvin J. Stone, Eugene P. Frenkel · The American Journal of Medicine · 1975 · 112 citations
Medicine, Hematology, Pathology +12
PRIMARY HYPERPARATHYROIDISM IN PARANEOPLASTIC HYPERCALCÆMIA
MarcK Drezner, HaroldE. Lebovitz · The Lancet · 1978 · 56 citations
Medicine, Endocrinology, Oncology +10